Fas ligand (FasL, Apo-1L) is a member of the tumor necrosis factor pro
tein family and binding to its receptor (Fas, Apo-1, CD95) triggers ce
ll death through apoptosis. Ligand expression is restricted to cells w
ith known cytolytic activity and found on hematopoietic cells of the T
cell and natural killer lineage. Here we provide evidence that B lymp
hocytes can express FasL. Flow cytometric analysis revealed that FasL
is expressed on the surface of B cells upon stimulation with either li
popolysaccharide or phorbol 12-myristute 13-acetate/ionomycin. FasL ex
pression on activated B cells was confirmed by Western blot and revers
e transcriptase polymerase chain reaction analysis. FasL on B cells is
functional since lipopolysaccharide-activated B lymphocytes derived f
rom wild type. but not fron gld mutant mice, were able to kill Fas-sen
sitive target cells. Our data suggest that the Fas system may contribu
te to the control of B cell homeostasis.